Companies: 10,795·Total market cap: $144.5T
Nuvation Bio Inc.

Nuvation Bio Inc.

NUVBNYSEHealthcare● Active
$4.82
$-0.35(-6.77%)
Market Cap$1.7B
P/E Ratio—
52W High$9.75
52W Low$1.57
SEC Filings

Nuvation Bio Inc. (NUVB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001811063 · NUVB · NYSE · as of Jun 8, 2026

Filing snapshot

380
Total Filings
8-K
Latest Form
2026-05-27
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001811063 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-02
Fiscal Year End
Mar 2, 2026
Accession No.
0001193125-26-085584
Primary Document
nuvb-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001811063 · Accession 0001193125-26-085584

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-04
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-27Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-27
View
8-KCurrent Report
8-K
2026-05-04
View
10-QQuarterly Report
10-Q
2026-05-04
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-21
View
ARSARS
ARS
2026-04-10
View
DEF 14AProxy Statement
DEF 14A
2026-04-10
View
S-8Employee Stock Plan Registration
S-8
2026-03-03
View
10-KAnnual Report
10-K
2026-03-02
View
8-KCurrent Report
8-K
2026-03-02
View
25-NSE25-NSE
25-NSE
2026-02-10
View
8-KCurrent Report
8-K
2026-01-12
View
8-KCurrent Report
8-K
2025-11-26
View
8-KCurrent Report
8-K
2025-11-17
View
S-8Employee Stock Plan Registration
S-8
2025-11-03
View
10-QQuarterly Report
10-Q
2025-11-03
View
Showing 1–15 of 220 filingsForm 4 / 144 hidden· 380 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001811063  |  Exchange: NYSE · Healthcare

Nuvation Bio Inc. (NYSE: NUVB) has submitted 380 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001811063, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Nuvation Bio Inc.'s most comprehensive regulatory disclosure. The most recent Nuvation Bio Inc. 10-K was filed on 2026-03-02 for fiscal year ending 2026. Historical NUVB 10-K annual reports are available from 2020 through 2026.

Investors researching Nuvation Bio Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
EWTX SEC Filings →VERA SEC Filings →GPCR SEC Filings →AUPH SEC Filings →CLDX SEC Filings →OCUL SEC Filings →ABCL SEC Filings →QURE SEC Filings →
→ NUVB Financials→ NUVB Earnings→ NUVB Insider Trades

Frequently Asked Questions

NUVB SEC Filings · 8 questions

Nuvation Bio Inc. (NUVB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 380 filings and access original documents at no cost. Nuvation Bio Inc.'s CIK is 0001811063.

NUVB SEC filingsNuvation Bio Inc. SEC documentsfind NUVB 10-K